The results of network pharmacology suggest that catalpol is involved in the regulation of inflammation, vascular homeostasis, and vascular remodeling after cerebral ischemia, which is closely related to F2, MMP9, VEGF/KDR, and ALB. The gene discussed is MMP9; the disease is brain ischemia.